[go: up one dir, main page]

DK161703C - Ferrikomplekser af hydroxypyridinforbindelser, farmaceutiske praeparater indeholdende saadanne komplekser, samt anvendelsen af saadanne komplekser til fremstilling af farmaceutiske praeparater - Google Patents

Ferrikomplekser af hydroxypyridinforbindelser, farmaceutiske praeparater indeholdende saadanne komplekser, samt anvendelsen af saadanne komplekser til fremstilling af farmaceutiske praeparater

Info

Publication number
DK161703C
DK161703C DK453584A DK453584A DK161703C DK 161703 C DK161703 C DK 161703C DK 453584 A DK453584 A DK 453584A DK 453584 A DK453584 A DK 453584A DK 161703 C DK161703 C DK 161703C
Authority
DK
Denmark
Prior art keywords
complexes
pharmaceutical preparations
complexs
fresh
preparation
Prior art date
Application number
DK453584A
Other languages
English (en)
Other versions
DK161703B (da
DK453584D0 (da
DK453584A (da
Inventor
Robert Charles Hider
George Kontoghiorghes
Jack Silver
Michael Arthur Stockham
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of DK453584D0 publication Critical patent/DK453584D0/da
Publication of DK453584A publication Critical patent/DK453584A/da
Publication of DK161703B publication Critical patent/DK161703B/da
Application granted granted Critical
Publication of DK161703C publication Critical patent/DK161703C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK453584A 1983-09-23 1984-09-21 Ferrikomplekser af hydroxypyridinforbindelser, farmaceutiske praeparater indeholdende saadanne komplekser, samt anvendelsen af saadanne komplekser til fremstilling af farmaceutiske praeparater DK161703C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8325496 1983-09-23
GB838325496A GB8325496D0 (en) 1983-09-23 1983-09-23 Pharmaceutical compositions

Publications (4)

Publication Number Publication Date
DK453584D0 DK453584D0 (da) 1984-09-21
DK453584A DK453584A (da) 1985-03-24
DK161703B DK161703B (da) 1991-08-05
DK161703C true DK161703C (da) 1992-01-20

Family

ID=10549201

Family Applications (1)

Application Number Title Priority Date Filing Date
DK453584A DK161703C (da) 1983-09-23 1984-09-21 Ferrikomplekser af hydroxypyridinforbindelser, farmaceutiske praeparater indeholdende saadanne komplekser, samt anvendelsen af saadanne komplekser til fremstilling af farmaceutiske praeparater

Country Status (11)

Country Link
US (1) US4587240A (da)
EP (1) EP0138420B1 (da)
JP (2) JPS6094966A (da)
CY (1) CY1574A (da)
DE (1) DE3480599D1 (da)
DK (1) DK161703C (da)
GB (2) GB8325496D0 (da)
GR (1) GR80444B (da)
HK (1) HK7091A (da)
SG (1) SG93290G (da)
ZA (1) ZA847409B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
US5010191A (en) * 1985-08-19 1991-04-23 The Regents Of The University Of California Imaging agents for in vivo magnetic resonance and scintigraphic imaging
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
GB8910521D0 (en) * 1989-05-08 1989-06-21 Nat Res Dev The stabilization of organic compounds
US5443813A (en) * 1991-06-06 1995-08-22 Associated Universities, Inc. Loading and conjugating cavity biostructures
ATE273702T1 (de) 1995-06-10 2004-09-15 Vitra Pharmaceuticals Ltd Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon
US5667933A (en) * 1996-02-26 1997-09-16 Polaroid Corporation Image-recording element
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
AU2725000A (en) 1999-01-13 2000-08-01 Bayer Corporation Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US7135196B2 (en) * 2000-09-19 2006-11-14 Vitra Pharmaceuticals Limited Iron compositions
DK1478358T3 (da) 2002-02-11 2013-10-07 Bayer Healthcare Llc Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
GB0211500D0 (en) * 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
US7595073B2 (en) * 2003-02-28 2009-09-29 Kraft Foods Global Brands Llc Use of siderophores and organic acids to retard lipid oxidation
JP2007511203A (ja) * 2003-05-20 2007-05-10 バイエル、ファーマシューテイカルズ、コーポレイション キナーゼ阻害活性を有するジアリール尿素
KR101139557B1 (ko) 2003-07-23 2012-04-30 바이엘 파마슈티칼스 코포레이션 질환 및 상태의 치료 및 예방을 위한 플루오로 치환오메가-카르복시아릴 디페닐 우레아
NZ600874A (en) 2007-03-28 2013-01-25 Apotex Technologies Inc Fluorinated derivatives of deferiprone
AP2010005454A0 (en) 2008-04-25 2010-12-31 Apotex Technologies Inc Liquid formulation for deferiprone with palatable taste.
CN102712591B (zh) 2009-07-03 2014-06-25 阿普泰克斯科技公司 3-羟基吡啶-4-酮的氟化衍生物
MX2012010950A (es) 2010-03-23 2012-11-12 Vifor Int Ag Compuestos del complejo de fe (iii) para el tratamiento y profilaxis de los sintomas de deficienza de hierro y las anemias por deficiencia de hierro.
EP2691376B1 (de) * 2011-03-29 2015-12-09 Vifor (International) AG Fe(iii)-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
EP2714030B1 (de) 2011-05-31 2015-08-12 Vifor (International) AG Fe(iii)-2,4-dioxo-1-carbonyl-komplexverbindungen zur verwendung bei der behandlung und der prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
CN104203245A (zh) * 2012-04-05 2014-12-10 维福（国际）股份有限公司 用于治疗和预防铁缺乏症和缺铁性贫血的铁(iii)复合化合物
JP6172691B2 (ja) 2012-12-21 2017-08-02 ヴィフォール （インターナショナル） アクチェンゲゼルシャフトＶｉｆｏｒ （Ｉｎｔｅｒｎａｔｉｏｎａｌ） ＡＧ 鉄欠乏症候群と鉄欠乏性貧血の治療と予防のための鉄（ｉｉｉ）錯体化合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2748142A (en) * 1956-05-29 - process of production
GB778871A (en) * 1955-02-14 1957-07-10 Sadolin & Holmblad As Pyridinediol oxides and acetates thereof and their preparation
GB790584A (en) * 1955-02-15 1958-02-12 Sadolin & Holmblad As Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
GB791719A (en) * 1955-02-15 1958-03-12 Sadolin & Holmblad As Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
FR3691M (fr) * 1963-05-06 1965-11-15 Olin Mathieson Nouvelle composition pharmaceutique utile en tant que fongicide.
US3968118A (en) * 1968-08-31 1976-07-06 Hoechst Aktiengesellschaft Process for the manufacture of 1-hydroxy-2-pyridones
NL156397B (nl) * 1968-08-31 1978-04-17 Hoechst Ag Werkwijze voor het bereiden van preparaten tegen schimmelaandoeningen, gevormde preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen.
US3705943A (en) * 1969-07-18 1972-12-12 Olin Corp Dialkyltin salts of substituted pyridine-1-oxides as fungicides and bactericides
EG10850A (en) * 1972-03-25 1976-06-30 Hoechst Ag Process for the preparation of 1-hydroxy-pyridones
DE2705562A1 (de) * 1977-02-10 1978-08-17 Basf Ag Verfahren zur herstellung von pyridonen
US4358455A (en) * 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
JPS5832812A (ja) * 1981-08-21 1983-02-25 Lion Corp 毛髪化粧料
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
GB2118176B (en) * 1982-03-24 1985-12-04 Nat Res Dev Pharmaceutical compositions
EP0105053B1 (en) * 1982-10-01 1988-01-20 Merck & Co. Inc. Aralkylaminoethanol heterocyclic compounds
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4698431A (en) * 1985-11-12 1987-10-06 The United States Of America As Represented By The United States Department Of Energy Hydroxypyridonate chelating agents

Also Published As

Publication number Publication date
DK161703B (da) 1991-08-05
GB8423800D0 (en) 1984-10-24
JPH05246992A (ja) 1993-09-24
US4587240A (en) 1986-05-06
CY1574A (en) 1991-12-20
GB8325496D0 (en) 1983-10-26
DK453584D0 (da) 1984-09-21
JPH0566385B2 (da) 1993-09-21
EP0138420A3 (en) 1987-05-20
JPS6094966A (ja) 1985-05-28
SG93290G (en) 1991-01-18
GR80444B (en) 1985-01-23
JPH0811729B2 (ja) 1996-02-07
EP0138420A2 (en) 1985-04-24
EP0138420B1 (en) 1989-11-29
DE3480599D1 (de) 1990-01-04
DK453584A (da) 1985-03-24
GB2146990B (en) 1987-05-20
ZA847409B (en) 1986-05-28
GB2146990A (en) 1985-05-01
HK7091A (en) 1991-02-01

Similar Documents

Publication Publication Date Title
DK161703C (da) Ferrikomplekser af hydroxypyridinforbindelser, farmaceutiske praeparater indeholdende saadanne komplekser, samt anvendelsen af saadanne komplekser til fremstilling af farmaceutiske praeparater
DK158349C (da) Ferrikomplekser af hydroxypyridinforbindelser samt farmaceutiske praeparater indeholdende saadanne komplekser
DK214090D0 (da) 5-aminosulfonylalkyl-indolderivater, fremgangsmaade og mellemprodukt til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK163958C (da) Analgetiske praeparater indeholdende n-phenylmethyl-cis-monoalkenamider
NO820200L (no) Fremgangsmaate til fremstilling av fosforylforbindelser, i foerste rekke heksapyranoseforbindelser samt farmasoeytiske preparater inneholdende disse
DK160492C (da) Pyrimidinderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse derivater
DK159305C (da) Ferrikomplekser af hydroxypyridinforbindelser samt farmaceutiske praeparater indeholdende saadanne komplekser
NO822391L (no) Karbostyrilforbindelser, preparater inneholdende disse og fremgangsmaater for fremstilling av forbindelsene
DK542584A (da) 1,3-dihydro-6-vinyl-7-hydroxy-furo-(3,4-c)pyridin-derivater, fremgangsmaade til fremstilling af disse samt farmaceutisk praeparat indeholdende disse
DK409784A (da) Substituerede phenyl-alifatiske isoxaler, fremgangsmaade til fremstilling deraf samt antivirale praeparater indeholdende disse
DK545684A (da) 1,3-dihydro-6-methyl-furo-(3,4-c)-pyridin-derivater, fremgangsmaade til fremstilling af disse samt farmaceutisk praeparat indeholdende disse
NO812464L (no) Fremgangsmaate til fremstilling av antiviralt virksomme forbindelser, samt preparater inneholdende disse
DK116380A (da) Bradykninhaemmende tripeptidforbindelser fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK159420C (da) N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
DK160986C (da) Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse
DK404879A (da) Kortikoid-21-sulfopropionater og deres salte fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse forbindelser
DK160763C (da) Imidazooe1,5-aaapyridiner og salte deraf samt deres 5,6,7,8-tetrahydroderivater, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelse af forbindelserne
DK418581A (da) Anthracyclin-derivater fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende disse forbindelser
DK591983A (da) 1-phenyllavalkyl-1h-1,2,3-triazolforbindelser og salte deraf samt farmaceutiske praeparater indeholdende disse forbindelser og fremgangsmaade til fremstilling deraf
DK567184D0 (da) Pyridonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse
NO830966L (no) Sulfonylurinstoffer, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser, og deres anvendelse
DK160885A (da) Benzazepinderivater, fremgangsmaade til fremstilling deraf samt praeparater indeholdende disse
DK93385D0 (da) 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
DK435382A (da) Praeparater med langvarig frigoerelse
DK163247C (da) Gonadolibeinderivater, farmaceutisk acceptable syreadditionssalte og complexer heraf samt en fremgangsmaade til fremstilling af disse og et farmaceutisk praeparat indeholdende disse

Legal Events

Date Code Title Description
PBP Patent lapsed